Table 3 Overview of pharmacologic treatment options for allergic rhinitis

 Bilastine (Blexten)

1 tablet (20 mg) once daily

For children ≥ 12 years of age: 1 tablet (20 mg) once daily

Not recommended for children < 12 years of age

 Cetirizine (Reactine)

1–2 tablets (5 mg) once daily

1 tablet (10 mg) once daily

5–10 mL (1–2 teaspoons) once daily (children’s formulation)

 Desloratadine (Aerius)

1 tablet (5 mg) once daily

2.5–5 mL (0.5–1.0 teaspoon) once daily (children’s formulation)

 Fexofenadine (Allegra)

1 tablet (60 mg) every 12 h (12-h formulation)

1 tablet (120 mg), once daily (24-h formulation)

Not currently indicated for children < 12 years of age

 Loratadine (Claritin)

1 tablet (10 mg), once daily

5–10 mL (1–2 teaspoons) once daily (children’s formulation)

 Rupatadine (Rupall)

1 tablet (10 mg) once daily

For children ≥ 12 years: 1 tablet (10 mg) once daily

For children 2–11 years and body weight 10–25 kg: 2.5 mL (0.5 teaspoon) once daily

For children 2–11 years and body weight > 25 kg: 5 mL (1.0 teaspoon) once daily

 Beclomethasone (Beconase)

1–2 sprays (50 µg/spray) EN, twice daily

1 spray (50 µg/spray) EN, twice daily

 Budesonide (Rhinocort)

2 sprays (64 μg/spray) EN, once daily or 1 spray EN, twice daily

2 sprays (64 μg/spray) EN, once daily or 1 spray EN, twice daily (do not exceed 256 μg)

 Ciclesonide (Omnaris)

2 sprays (50 µg/spray) EN, once daily

Not indicated for children < 12 years of age

 Fluticasone furoate (Avamys)

2 sprays (27.5 µg/spray) EN, once daily

1 spray (27.5 µg/spray) EN, once daily

 Fluticasone propionate (Flonase)

2 sprays (50 µg/spray) EN, once daily or every 12 h (for severe rhinitis)

1–2 sprays (50 µg/spray) EN, once daily

 Mometasone furoate (Nasonex)

2 sprays (50 µg/spray) EN, once daily

1 spray (50 µg/spray) EN, once daily

 Triamcinolone acetonide (Nasacort)

2 sprays (55 µg/spray) EN, once daily

1 spray (55 µg/spray) EN, once daily

 Fluticasone propionate/azelastine hydrochloride (Dymista)

1 spray EN, twice daily

For children ≥ 12 years of age: 1 spray EN, twice daily

Not recommended for children < 12 years of age

 Montelukast

1 tablet (10 mg), once daily

Not currently approved for patients < 15 years of age